申林凯辛颗粒通过多目标机制减轻抑郁症:来自CSDS模型和细胞研究的证据
Wenjie Ji1, Wenxue Zhao2, Yan Xu2
1School of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.
概括
深灵凯辛颗粒 (SLKX) 通过准神经,免疫和代谢通路,有效地治疗小鼠的类似抑郁症的行为. 这项研究提供了SLKX作为潜在的新型抗抑郁药干预措施的证据.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 重度抑郁症 (MDD) 是一种流行且具有复杂原因的致残性疾病,包括神经递质失衡,神经炎症,氧化应激和神经可塑性受损.
- 目前的抑郁症治疗方法在疗效和副作用方面存在局限性,需要开发更安全,更有效的替代方案.
研究的目的:
- 为了研究神灵凯辛颗粒 (SLKX) 在抑郁症小鼠模型中的抗抑郁作用.
- 用体内和体外方法阐明SLKX作用的潜在分子和细胞机制.
主要方法:
- 建立了一个慢性社会失败压力 (CSDS) 鼠标模型,用于类似抑郁症的行为.
- 给小鼠服用不同剂量的SLKX,并评估行为,生化和分子变化.
- 使用UPLC-MS进行化学分析,ELISA用于神经递质和细胞因子量化,西布局用于蛋白质分析,以及各种行为测试.
- 使用免疫光,TUNEL染色,传输电子显微镜和代谢学进行全面分析.
- 使用皮质激素 (CORT) 诱导的SH-SY5Y细胞损伤模型与PI3K抑制剂LY294002用于在体外验证关键途径.
主要成果:
- 在CSDS小鼠中,SLKX治疗显著减少了类似抑郁症的行为,并恢复了海马神经递质平衡.
- 在机械上,SLKX激活了抗氧化剂 (Nrf2/HO-1) 和神经可塑性 (PI3K/AKT/CREB-BDNF) 途径,同时抑制了炎症 (TLR4/NF-κB) 和亡.
- 在实验室中,SLKX纠正了代谢障碍,并证明了抗抑郁剂,抗氧化剂和神经变效应,PI3K/AKT介导的Nrf2和CREB/BDNF信号被证实是关键的.
- UPLC-MS 在SLKX中确定了26个可能对其治疗活性负责的成分.
结论:
- 通过多目标机制通过神经-免疫-内分泌-代谢网络的协同调节,SLKX表现出抗抑郁作用.
- 来自动物和细胞研究的发现支持SLKX.提议的机制.
- 这项研究为SLKX在治疗抑郁症的潜在临床应用奠定了基础.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
784
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
784
G-protein Coupled Receptors
131.4K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
131.4K
Long-term Depression
33.0K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.0K
Long-term Depression
3.1K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.1K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
1.3K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
1.3K


